Your browser doesn't support javascript.
loading
ERAP1 and ERAP2 Enzymes: A Protective Shield for RAS against COVID-19?
D'Amico, Silvia; Tempora, Patrizia; Lucarini, Valeria; Melaiu, Ombretta; Gaspari, Stefania; Algeri, Mattia; Fruci, Doriana.
Afiliación
  • D'Amico S; Department of Paediatric Haematology/Oncology and of Cell and Gene Therapy, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146 Rome, Italy.
  • Tempora P; Department of Paediatric Haematology/Oncology and of Cell and Gene Therapy, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146 Rome, Italy.
  • Lucarini V; Department of Paediatric Haematology/Oncology and of Cell and Gene Therapy, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146 Rome, Italy.
  • Melaiu O; Department of Paediatric Haematology/Oncology and of Cell and Gene Therapy, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146 Rome, Italy.
  • Gaspari S; Department of Paediatric Haematology/Oncology and of Cell and Gene Therapy, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146 Rome, Italy.
  • Algeri M; Department of Paediatric Haematology/Oncology and of Cell and Gene Therapy, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146 Rome, Italy.
  • Fruci D; Department of Paediatric Haematology/Oncology and of Cell and Gene Therapy, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146 Rome, Italy.
Int J Mol Sci ; 22(4)2021 Feb 08.
Article en En | MEDLINE | ID: mdl-33567739
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sistema Renina-Angiotensina / Antígenos de Histocompatibilidad Menor / Enzima Convertidora de Angiotensina 2 / SARS-CoV-2 / COVID-19 / Aminopeptidasas / Hipertensión Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Int J Mol Sci Año: 2021 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sistema Renina-Angiotensina / Antígenos de Histocompatibilidad Menor / Enzima Convertidora de Angiotensina 2 / SARS-CoV-2 / COVID-19 / Aminopeptidasas / Hipertensión Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Int J Mol Sci Año: 2021 Tipo del documento: Article País de afiliación: Italia